-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Harvard Bioscience Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Harvard Bioscience Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$2.07M, a 360% decline year-over-year.
- Harvard Bioscience Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$5M, a 199% decline year-over-year.
- Harvard Bioscience Inc annual Operating Income (Loss) for 2023 was $1.89M.
- Harvard Bioscience Inc annual Operating Income (Loss) for 2022 was -$6.93M, a 436% decline from 2021.
- Harvard Bioscience Inc annual Operating Income (Loss) for 2021 was $2.07M, a 835% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)